FDA.reportPublic FDA data

Alfuzosin Hydrochloride

Product NDC
47335-956
11-digit product format
473350956
Labeler code
47335
Product ID
47335-956_70258299-7c72-4a10-8d0c-4a5e3b2a0fc8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Alfuzosin Hydrochloride
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Sun Pharmaceutical Industries, Inc.
Application
ANDA079057
Marketing category
ANDA
Marketing start
2011-11-22
Substance
ALFUZOSIN HYDROCHLORIDE
Active strength
10 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A079057-001ALFUZOSIN HYDROCHLORIDEALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORAL2011-07-18

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORAL2011-07-18011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORAL2011-07-1831067a03dcf5…
2025-08-23 18:47 UTC2025-08A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORAL2011-07-186a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORAL2011-07-18fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORAL2011-07-18b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORAL2011-07-1803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORAL2011-07-182680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-185bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-1879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-181e350fbaab3a…
2024-05-31 18:47 UTC2024-05A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-188072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-185c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-185d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-184b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-1874a2ff9319b5…
2022-03-09 01:35 UTC2022-03A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-1887673890dc5c…
2021-03-12 10:30 UTC2021-03A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-185aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-188869cabd3fbd…
2020-11-12 02:37 UTC2020-11A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18c0c555d07b60…
2019-12-14 00:12 UTC2019-12A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-183f01610625f2…
2019-09-15 20:21 UTC2019-09A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18b00525d2431f…
2019-07-19 19:46 UTC2019-07A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-186a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-181c564ffb4f44…
2023-12-20 04:57 UTC2023-12A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-189b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-183f0d92c62455…
2023-05-13 08:27 UTC2023-05A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18053a50430f4f…
2023-01-26 05:58 UTC2023-01A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-183bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-183a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A079057-001ALFUZOSIN HYDROCHLORIDE10MGTABLET, EXTENDED RELEASE / ORALAB2011-07-18cb3db0bc1861…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A079057-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A079057-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A079057-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A079057-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A079057-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A079057-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A079057-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A079057-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A079057-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A079057-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A079057-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A079057-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A079057-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A079057-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A079057-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A079057-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A079057-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A079057-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A079057-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A079057-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A079057-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A079057-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A079057-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A079057-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A079057-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A079057-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A079057-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A079057-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A079057-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A079057-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A079057-001AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A079057-001AB1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A079057-001AB1cb3db0bc1861…

Additional Listing Data#

Finished product
Yes
Brand name base
Alfuzosin Hydrochloride
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ALFUZOSIN HYDROCHLORIDE10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
75046A1XTNInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
861132Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
d2af616e-673a-4fdd-ace8-db2d0f154604Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
8b671e1a-6f8a-5de4-69a7-83132df7952dProduct name320201015

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
47335-956-08Alfuzosin Hydrochloride100 in 1 BOTTLETABLET, EXTENDED RELEASE10015
47335-956-18Alfuzosin Hydrochloride1000 in 1 BOTTLETABLET, EXTENDED RELEASE100015
47335-956-81Alfuzosin Hydrochloride90 in 1 BOTTLETABLET, EXTENDED RELEASE9015
47335-956-83Alfuzosin Hydrochloride30 in 1 BOTTLETABLET, EXTENDED RELEASE3015
47335-956-88Alfuzosin Hydrochloride100 in 1 BOTTLETABLET, EXTENDED RELEASE10015

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
47335-956-18EA - Each47335-9567b08db97-7ad5-4659-b8f5-ce1eec53d17112012-07-24
47335-956-81EA - Each47335-956603c57cc-9d96-49c6-97ca-fe083414978a12012-07-24
47335-956-88EA - Each47335-9566f86c33a-e20b-4cff-bbff-2d87b832230712012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ALFUZOSIN HYDROCHLORIDEACTIVE INGREDIENT75046A1XTNALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]8
ALFUZOSINACTIVE MOIETY90347YTW5FALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]8
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]8
HYDROXYPROPYL CELLULOSE (TYPE H)INACTIVE INGREDIENTRFW2ET671PALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]8
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]8
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]8
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]8
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]8
TALCINACTIVE INGREDIENT7SEV7J4R1UALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]8
ALFUZOSIN HYDROCHLORIDEACTIVE INGREDIENT75046A1XTNALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC]2
ALFUZOSINACTIVE MOIETY90347YTW5FALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC]2
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC]2
HYDROXYPROPYL CELLULOSE (TYPE H)INACTIVE INGREDIENTRFW2ET671PALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC]2
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC]2
TALCINACTIVE INGREDIENT7SEV7J4R1UALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AIDAREX PHARMACEUTICALS LLC]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
47335-956ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMACEUTICAL INDUSTRIES, INC.]15Current NDC, Legacy NDC, 5 package rows20240120_d2af616e-673a-4fdd-ace8-db2d0f154604.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Alfuzosin HydrochlorideALFUZOSIN HYDROCHLORIDENorthwind Health Company, LLCf2f42c98-4118-5f70-e053-2a95a90add022026-01-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 079057
application number: ANDA079057
Alfuzosin HydrochlorideALFUZOSIN HYDROCHLORIDEBryant Ranch Prepack3a541efa-9eed-4a27-b602-7999fc6f59aa2024-07-16Warnings, Adverse reactionsExact identifier
application applno (ANDA): 079057
application number: ANDA079057
Alfuzosin HydrochlorideALFUZOSIN HYDROCHLORIDEBryant Ranch Prepack98fa10c2-7c12-44aa-9112-e2fd6fa71d062024-04-03Warnings, Adverse reactionsExact identifier
application applno (ANDA): 079057
application number: ANDA079057
Alfuzosin HydrochlorideALFUZOSIN HYDROCHLORIDESun Pharmaceutical Industries, Inc.d2af616e-673a-4fdd-ace8-db2d0f1546042024-01-19Warnings, Adverse reactionsExact identifier
application applno (ANDA): 079057
application number: ANDA079057
ndc (product): 47335-956

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
861132alfuzosin HCl 10 MG 24HR Extended Release Oral TabletPSN98fa10c2-7c12-44aa-9112-e2fd6fa71d06104
86113224 HR alfuzosin hydrochloride 10 MG Extended Release Oral TabletSCD98fa10c2-7c12-44aa-9112-e2fd6fa71d06104
861132alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral TabletSY98fa10c2-7c12-44aa-9112-e2fd6fa71d06104
861132alfuzosin HCl 10 MG 24HR Extended Release Oral TabletPSN3a541efa-9eed-4a27-b602-7999fc6f59aa100
86113224 HR alfuzosin hydrochloride 10 MG Extended Release Oral TabletSCD3a541efa-9eed-4a27-b602-7999fc6f59aa100
861132alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral TabletSY3a541efa-9eed-4a27-b602-7999fc6f59aa100
861132alfuzosin HCl 10 MG 24HR Extended Release Oral TabletPSNd2af616e-673a-4fdd-ace8-db2d0f15460415
86113224 HR alfuzosin hydrochloride 10 MG Extended Release Oral TabletSCDd2af616e-673a-4fdd-ace8-db2d0f15460415
861132alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral TabletSYd2af616e-673a-4fdd-ace8-db2d0f15460415
861132alfuzosin HCl 10 MG 24HR Extended Release Oral TabletPSNf2f42c98-4118-5f70-e053-2a95a90add024
86113224 HR alfuzosin hydrochloride 10 MG Extended Release Oral TabletSCDf2f42c98-4118-5f70-e053-2a95a90add024
861132alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral TabletSYf2f42c98-4118-5f70-e053-2a95a90add024
861132alfuzosin HCl 10 MG 24HR Extended Release Oral TabletPSN8b256346-9450-54b5-e053-2995a90ae2593
86113224 HR alfuzosin hydrochloride 10 MG Extended Release Oral TabletSCD8b256346-9450-54b5-e053-2995a90ae2593
861132alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral TabletSY8b256346-9450-54b5-e053-2995a90ae2593
861132alfuzosin HCl 10 MG 24HR Extended Release Oral TabletPSN94458f26-9269-4fbc-80db-adc43b1fc62f2
861132alfuzosin HCl 10 MG 24HR Extended Release Oral TabletPSN27f6bec9-90a9-4c4c-e054-00144ff8d46c2
86113224 HR alfuzosin hydrochloride 10 MG Extended Release Oral TabletSCD94458f26-9269-4fbc-80db-adc43b1fc62f2
86113224 HR alfuzosin hydrochloride 10 MG Extended Release Oral TabletSCD27f6bec9-90a9-4c4c-e054-00144ff8d46c2
861132alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral TabletSY94458f26-9269-4fbc-80db-adc43b1fc62f2
861132alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral TabletSY27f6bec9-90a9-4c4c-e054-00144ff8d46c2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
47335-956-0847335095608100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-08) 2011-11-220000-00-00NoNoCurrent
47335-956-18473350956181000 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-18) 2011-11-220000-00-00NoNoCurrent
47335-956-814733509568190 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-81) 2011-11-220000-00-00NoNoCurrent
47335-956-834733509568330 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-83) 2011-11-220000-00-00NoNoCurrent
47335-956-8847335095688100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-88) 2011-11-220000-00-00NoNoCurrent